Free Trial

Cadre (CDRE) Competitors

Cadre logo
$36.18 +0.15 (+0.42%)
As of 03:59 PM Eastern

CDRE vs. NARI, IRTC, TMDX, BLCO, INSP, SLNO, PRCT, NVST, LIVN, and WRBY

Should you be buying Cadre stock or one of its competitors? The main competitors of Cadre include Inari Medical (NARI), iRhythm Technologies (IRTC), TransMedics Group (TMDX), Bausch + Lomb (BLCO), Inspire Medical Systems (INSP), Soleno Therapeutics (SLNO), PROCEPT BioRobotics (PRCT), Envista (NVST), LivaNova (LIVN), and Warby Parker (WRBY). These companies are all part of the "medical equipment" industry.

Cadre vs. Its Competitors

Inari Medical (NASDAQ:NARI) and Cadre (NYSE:CDRE) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, media sentiment, profitability, institutional ownership, valuation, community ranking, earnings, analyst recommendations and dividends.

Cadre has higher revenue and earnings than Inari Medical. Inari Medical is trading at a lower price-to-earnings ratio than Cadre, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Inari Medical$493.63M9.48-$1.64M-$1.35-59.24
Cadre$559.81M2.63$38.64M$0.9538.08

Inari Medical received 50 more outperform votes than Cadre when rated by MarketBeat users. Likewise, 57.89% of users gave Inari Medical an outperform vote while only 55.17% of users gave Cadre an outperform vote.

CompanyUnderperformOutperform
Inari MedicalOutperform Votes
66
57.89%
Underperform Votes
48
42.11%
CadreOutperform Votes
16
55.17%
Underperform Votes
13
44.83%

In the previous week, Cadre had 3 more articles in the media than Inari Medical. MarketBeat recorded 4 mentions for Cadre and 1 mentions for Inari Medical. Cadre's average media sentiment score of 1.42 beat Inari Medical's score of 0.76 indicating that Cadre is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Inari Medical
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Cadre
3 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

91.0% of Inari Medical shares are owned by institutional investors. Comparatively, 44.0% of Cadre shares are owned by institutional investors. 10.6% of Inari Medical shares are owned by insiders. Comparatively, 37.0% of Cadre shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Cadre has a net margin of 6.34% compared to Inari Medical's net margin of -13.68%. Cadre's return on equity of 12.88% beat Inari Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Inari Medical-13.68% -10.09% -6.60%
Cadre 6.34%12.88%6.06%

Inari Medical currently has a consensus price target of $69.22, suggesting a potential downside of 13.44%. Cadre has a consensus price target of $37.00, suggesting a potential upside of 2.27%. Given Cadre's stronger consensus rating and higher probable upside, analysts plainly believe Cadre is more favorable than Inari Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Inari Medical
0 Sell rating(s)
12 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.14
Cadre
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

Inari Medical has a beta of 1.02, suggesting that its share price is 2% more volatile than the S&P 500. Comparatively, Cadre has a beta of 1.36, suggesting that its share price is 36% more volatile than the S&P 500.

Summary

Cadre beats Inari Medical on 13 of the 18 factors compared between the two stocks.

Get Cadre News Delivered to You Automatically

Sign up to receive the latest news and ratings for CDRE and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CDRE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CDRE vs. The Competition

MetricCadreSurgical appliances & supplies IndustryIndustrials SectorNYSE Exchange
Market Cap$1.47B$9.20B$7.80B$19.87B
Dividend Yield1.12%1.26%4.56%3.83%
P/E Ratio43.5920.9225.4935.60
Price / Sales2.6345.67118.3543.81
Price / Cash22.8919.6726.8417.51
Price / Book6.895.134.234.85
Net Income$38.64M$284.66M$807.24M$1.02B
7 Day Performance6.46%0.35%1.34%1.94%
1 Month Performance1.21%-4.84%9.41%3.02%
1 Year Performance6.19%-20.86%25.62%9.87%

Cadre Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CDRE
Cadre
2.9984 of 5 stars
$36.18
+0.4%
$37.00
+2.3%
+7.1%$1.47B$559.81M43.592,240
NARI
Inari Medical
0.4866 of 5 stars
$79.97
flat
$69.22
-13.4%
N/A$4.68B$493.63M-59.24800News Coverage
IRTC
iRhythm Technologies
1.2946 of 5 stars
$140.65
+0.1%
$133.73
-4.9%
+59.0%$4.49B$618.59M-38.641,790Analyst Forecast
TMDX
TransMedics Group
1.3373 of 5 stars
$123.94
-2.5%
$126.70
+2.2%
+2.8%$4.19B$488.23M131.85210
BLCO
Bausch + Lomb
4.3927 of 5 stars
$11.46
-0.1%
$15.50
+35.3%
-16.3%$4.05B$4.83B-12.5912,500Analyst Forecast
INSP
Inspire Medical Systems
4.8331 of 5 stars
$133.66
-3.3%
$211.91
+58.5%
-19.9%$3.94B$840.11M77.26760Positive News
SLNO
Soleno Therapeutics
4.8194 of 5 stars
$75.66
+3.1%
$106.78
+41.1%
+70.5%$3.81BN/A-22.7930Positive News
Analyst Revision
PRCT
PROCEPT BioRobotics
1.9071 of 5 stars
$57.94
-0.1%
$90.00
+55.3%
-7.4%$3.21B$249.12M-29.71430Positive News
NVST
Envista
3.4007 of 5 stars
$18.09
-1.0%
$20.23
+11.8%
+5.9%$3.07B$2.50B-2.7912,700Positive News
LIVN
LivaNova
3.1747 of 5 stars
$43.41
+0.4%
$59.29
+36.6%
-9.8%$2.37B$1.28B103.362,900
WRBY
Warby Parker
2.084 of 5 stars
$21.49
+1.5%
$22.88
+6.4%
+35.5%$2.25B$795.09M-79.603,030Positive News

Related Companies and Tools


This page (NYSE:CDRE) was last updated on 6/12/2025 by MarketBeat.com Staff
From Our Partners